• Sample Page

Targeting the ubiquitin–proteasome system for cancer therapy

EAAT

Repeated cycles of ethanol intoxication and withdrawal associated with dependence induce

June 9, 2017 by Katherine Lewis Leave a Comment

Repeated cycles of ethanol intoxication and withdrawal associated with dependence induce neuroadaptations in a variety of brain systems. when ethanol-dependent male Wistar rats were qualified to self-administer ethanol and then assigned to either acute or chronic MMP inhibition treatment organizations. The chronic treatment group received intracerebroventricular (ICV) infusions of the broad spectrum MMP inhibitor FN-439 … [Read more…]

Posted in: EAAT Tagged: Dasatinib, Rabbit Polyclonal to OR10G4.

Purpose of the review B-cell tumors originating from the transformation of

June 6, 2017 by Katherine Lewis Leave a Comment

Purpose of the review B-cell tumors originating from the transformation of germinal center (GC) B-cells frequently harbor genetic mutations leading to constitutive activation of CCNB1 the nuclear factor-(encoding BLIMP1)[8 9 As a result the deregulated expression or inactivation of those genes disturbs the normal physiology of the GC-reaction by exerting pro-survival or pro-proliferative effects or … [Read more…]

Posted in: EAAT Tagged: CCNB1, Norfluoxetine

We developed an over-all cell-based photocrosslinking method of investigate the binding

May 19, 2017 by Katherine Lewis Leave a Comment

We developed an over-all cell-based photocrosslinking method of investigate the binding interfaces essential for the forming of G protein-coupled receptor (GPCR) signaling complexes. to CVX15. GPCRs are powerful membrane protein that cause and regulate mobile signaling pathways. In the traditional paradigm of GPCR signaling an extracellular ligand binds to a particular receptor to activate a … [Read more…]

Posted in: EAAT Tagged: Mertk, SB-715992

Copyright © 2026 Targeting the ubiquitin–proteasome system for cancer therapy.

Omega Child WordPress Theme by